M. C. Conroy

发表

Contribution of the C-terminal domain of metalloproteinases to binding by tissue inhibitor of metalloproteinases. C-terminal truncated stromelysin and matrilysin exhibit equally compromised binding affinities as compared to full-length stromelysin.

Q. Ye, J. Shipley, H. Welgus, 1994, The Journal of biological chemistry.

[Urticarial skin reaction to codeine, a measure of mast cell reactivity].

A. D. de Weck, M. C. Conroy, T. Berther, 1980, Schweizerische medizinische Wochenschrift.

Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955.

R. Gilbertsen, M. C. Conroy, J. Sircar, 1992, Biochemical pharmacology.

Inhibition of histamine, leukotriene C4/D4, and thromboxane B2 release from human leukocytes and human chopped lung mast cells by the allergic mediator release inhibitor, CI-949.

M. C. Conroy, C. Wright, D. Thueson, 1990, The Journal of allergy and clinical immunology.

Measurement of IgE on human basophils: relation to serum IgE and anti-IgE-induced histamine release.

L. Lichtenstein, N. Adkinson, M. C. Conroy, 1977, Journal of immunology.

IgE receptors on human basophils. Relationship to serum IgE concentration.

L. Lichtenstein, N. Adkinson, M. C. Conroy, 1978, The Journal of clinical investigation.

Differences between histamine release from rat mast cells and human basophils and mast cells

L. Lichtenstein, G. Marone, J. Foreman, 1979 .

Spontaneous, in vitro, malignant transformation of a basophil/mast cell line.

C. Heusser, J. M. Davis, M. C. Conroy, 1983, Differentiation; research in biological diversity.

Differential regulation of human eosinophil, macrophage, and neutrophil functions by the allergic mediator release inhibitor CI-959

M. C. Conroy, C. Wright, D. Thueson, 1992, Agents and Actions.

Differential regulation of the activation of human eosinophils, macrophages, and neutrophils: Effect of the allergic mediator release inhibitor CI-949

M. C. Conroy, C. Wright, D. Thueson, 1990, Agents and Actions.

Release of slow reacting substance of anaphylaxis (SRS-A) from human leukocytes by the calcium ionophore A23187.

L. Lichtenstein, M. C. Conroy, R. Orange, 1976, Journal of immunology.

CI-949: a new, potential antiallergy compound inhibits antigen-induced allergic reactions in guinea-pigs in vitro and in vivo.

M. C. Conroy, M. Finkel, D. Thueson, 1990, Pulmonary pharmacology.

Streptococcal cell wall-induced arthritis: requirements for IL-4, IL-10, IFN-gamma, and monocyte chemoattractant protein-1.

P. Ward, J. Warren, C. Flory, 1998, Journal of immunology.

Releasability — a New Dimension in Basophil and Mast Cell Reactivity

M. C. Conroy, 1981 .

RELATIONSHIP TO SERUM IgE CONCENTRATION

L. Lichtenstein, M. C. Conroy, F. Malveaux, 1978 .

Differential inhibition of histamine release from human basophils induced by antigen, anti-IgE or N-formyl-L-methionyl-L-leucyl-L-phenylalanine.

M. C. Conroy, D. Thueson, J. A. Kennedy, 1985, International archives of allergy and applied immunology.

Selective regulation of human neutrophil functions by the cell activation inhibitor CI‐959

M. C. Conroy, C. Wright, M. Hoffman, 1994, Journal of leukocyte biology.

Inhibition of Human Neutrophil Activation by the Allergic Mediator Release Inhibitor, CI‐949

M. C. Conroy, C. Wright, M. Hoffman, 1991, Journal of leukocyte biology.

Release of Histamine from Human Leukocytes by One Preparation of IgG Oligomers *

M. C. Conroy, A. Weck, T. Zhou, 1985, Allergy.

Evaluation of 3H‐Histamine Incorporation into Human Peripheral Blood Leukocytes

M. C. Conroy, A. Weck, M. Barazarte, 1982, Allergy.

The pharmacologic effects of 5-[3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl]-1,3,4-thiadiazole-2(3H)-thione, choline salt (CI-986), a novel inhibitor of arachidonic acid metabolism in models of inflammation, analgesia and gastric irritation.

R. D. Dyer, M. D. Mullican, R. Dyer, 1994, Prostaglandins.

IgG4 as Blocking or Anaphylactic Antibody

M. C. Conroy, A. Weck, T. Zhou, 1983 .

Inhibition of human neutrophil activation by the allergic mediator release inhibitor, CI-922: mechanism of inhibitory activity.

M. C. Conroy, C. Wright, M. Hoffman, 1987, Biochemical and biophysical research communications.

Inhibition of Human Neutrophil Activation by the Allergic Mediator Release Inhibitor, CI‐922: Differential Inhibition of Responses to a Variety of Stimuli

M. C. Conroy, C. Wright, M. Hoffman, 1987, Journal of leukocyte biology.

Streptococcal cell wall-induced arthritis. Requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2.

P. Ward, J. Dykens, C. Flory, 1997, Journal of immunology.

Generation by Bacterial Proteinases of Leukotactic Factors from Human Serum, and Human C3 and C5

P. Ward, M. C. Conroy, I. Lepow, 1973, The Journal of Immunology.

Effects in the Rat of Intradermal Injection of Purified Proteinases from Streptococcus and Serratia Marcescens 1

N. Bander, M. C. Conroy, I. Lepow, 1975, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Novel thiophene-, pyrrole-, furan-, and benzenecarboxamidotetrazoles as potential antiallergy agents.

M. D. Mullican, R. Sorenson, D. T. Connor, 1991, Journal of medicinal chemistry.

Novel indolecarboxamidotetrazoles as potential antiallergy agents.

D. T. Connor, P. Unangst, M. C. Conroy, 1989, Journal of medicinal chemistry.

Hypersensitivity Reactions to Hormones

M. C. Conroy, A. Weck, 1983 .

Cytoprotective effects of CI-959 in the rat gastric mucosa: modulation of leukocyte adhesion.

J. Wallace, D. Schrier, A. Metz, 1995, Gastroenterology.

Selective in vitro inhibition of human MOLT-4 T lymphoblasts by the novel purine nucleoside phosphorylase inhibitor, CI-972.

R. Gilbertsen, M. C. Conroy, C. Kostlan, 1991, Biochemical and biophysical research communications.

Failure of covalently cross-linked human IgG myeloma subclass protein to release histamine from human leukocytes.

A. D. de Weck, M. C. Conroy, T. Zhou, 1984, International archives of allergy and applied immunology.

Skin reactivity, basophil degranulation and IgE levels in ageing

H. Schwarzenbach, M. C. Conroy, T. Nakagawa, 1982, Clinical allergy.

Activities of Two 9‐Deazaguanine Analogue Inhibitors of Purine Nucleoside Phosphorylase, CI‐972 and PD 141955, in Vitro and in Vivo

R. Gilbertsen, M. C. Conroy, J. Sircar, 1993, Annals of the New York Academy of Sciences.

Pharmacology, Pharmacokinetics, and Therapeutic Use of Meclofenamate Sodium

E. Randinitis, M. C. Conroy, J. Turner, 1991, The Clinical journal of pain.

Inhibition of E-Selectin-, ICAM-1, and VCAM-1-Mediated Cell Adhesion by Benzo(b)thiophene-, Benzofuran-, Indole-, and Naphthalene-2- carboxamides: Identification of PD 144795 as an Antiinflammatory Agent.

D. Boschelli, R. Sorenson, D. T. Connor, 1996 .

Effect of Aspirin and Indomethacin on Histamine Release from Leukocytes of Patients with Suspected Intolerance to Aspirin

M. C. Conroy, A. Weck, 1981 .

Biochemical and pharmacological properties of CI-972, a novel 9-deazaguanine analog purine nucleoside phosphorylase (PNP) inhibitor.

R. Gilbertsen, M. C. Conroy, C. Kostlan, 1991, Advances in Experimental Medicine and Biology.

Specific inhibition of phorbol ester and DiC8-induced histamine release from human basophils by the protein kinase C inhibitors, H-7 and H-9.

M. C. Conroy, C. Wright, D. Thueson, 1987, Biochemical and biophysical research communications.